OTC antacids may modestly improve glucose in type 2 diabetes

OTC antacids may modestly improve glucose in type 2 diabetes

Add-on proton pump inhibitor therapy improved glycemic markers among adults with type 2 diabetes, but did not alter risk for incident diabetes, according to a meta-analysis published in The Journal of Clinical Endocrinology & Metabolism.There is a higher prevalence of upper gastrointestinal symptoms among adults with diabetes, especially among those with poor glycemic response, Kashif M. Munir, MD, vice chief and associate professor of medicine in the division of endocrinology, diabetes and nutrition at the University of Maryland School of Medicine, and colleagues wrote in the studyRead More

Share on facebook
Share on twitter
Share on linkedin